Early Intervention for Information Processing Speed Deficits in Acute SCI: A Pilot Study
Launched by KESSLER FOUNDATION · Jun 5, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether a special cognitive training program can help improve the speed at which people with recent spinal cord injuries (SCI) process information. The goal is to see if this training can make everyday tasks easier for individuals who have experienced a traumatic SCI within the last six months.
To participate in the study, individuals need to be between 18 and 65 years old and must have suffered a recent traumatic spinal cord injury. It’s important that they do not have other significant neurological issues, psychiatric conditions, or serious vision problems. If eligible, participants can expect to engage in cognitive training exercises designed to enhance their processing speed, which could help them in their daily lives. The study is currently looking for volunteers to join, and contributions from participants may help improve care for others with similar injuries in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18-65 years old
- • recent traumatic SCI (approximately 6 months post-injury)
- Exclusion Criteria:
- • no other significant neurological, psychiatric or substance use history
- • no significantly impairing visual disturbance
About Kessler Foundation
Kessler Foundation is a leading nonprofit organization dedicated to advanced rehabilitation research and the development of innovative strategies to improve the lives of individuals with disabilities. With a strong emphasis on clinical trials and evidence-based practices, the Foundation collaborates with academic institutions, healthcare providers, and industry partners to explore novel therapeutic approaches and technologies. Its commitment to enhancing mobility, cognitive function, and overall quality of life for people with neurological and musculoskeletal conditions drives its mission to transform rehabilitation outcomes through cutting-edge research and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
East Hanover, New Jersey, United States
Patients applied
Trial Officials
Erica Weber, PhD
Principal Investigator
Kessler Foundation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported